In a study characterising the roles of ICAM-1 and VCAM-1 during colitis, Sans et al [50] highlighted the therapeutic potential of VCAM-1 antibody blockade for preventing pathological leukocyte infiltration and associated intestinal inflammation. This evidence concerns the gene ICAM1 and colitis.